Therapeutic Use of Extraembryonic-Derived Tissues

Instead as being seen as medical waste, umbilical cord blood (UCB), placenta-derived cells, and other extraembryonic tissue are increasingly accepted as a high-quality source of cells for therapeutic use.The best-known application is the transplantation of hematopoietic stem cells (HSCT), while UCB...

Full description

Saved in:
Bibliographic Details
Published in:Stem cells international 2018-01, Vol.2018, p.6082698-2
Main Authors: Uhlin, Michael, Abumaree, Mohamed, Abdelalim, Essam M.
Format: Article
Language:English
Subjects:
Cord blood
Endometriosis
Genotype & phenotype
Health aspects
Hematopoietic stem cells
Medical wastes
Medicin och hälsovetenskap
Menstruation
Placenta
Stem cell transplantation
Stem cells
Transplantation
Umbilical cord
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Instead as being seen as medical waste, umbilical cord blood (UCB), placenta-derived cells, and other extraembryonic tissue are increasingly accepted as a high-quality source of cells for therapeutic use.The best-known application is the transplantation of hematopoietic stem cells (HSCT), while UCB has become an increasingly important graft source since UCB transplantation (UCBT) has been implemented in the last 3 decades.The nonhematopoietic stem cell types in UCB as well as placenta-derived and extraembryonic cells and tissues include several types that can be used therapeutically and are readily expanded to sufficient numbers using established methods.
ISSN:1687-966X
1687-9678
1687-9678
DOI:10.1155/2018/6082698